Changmao Biochemical Engineering Co (HKSE:00954) Accounts Payable & Accrued Expense : HK$114.6 Mil (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Accounts Payable & Accrued Expense?

Changmao Biochemical Engineering Co's quarterly accounts payable & accrued expense declined from Jun. 2022 (HK$120.6 Mil) to Dec. 2022 (HK$74.3 Mil) but then increased from Dec. 2022 (HK$74.3 Mil) to Jun. 2023 (HK$114.6 Mil).

Changmao Biochemical Engineering Co's annual accounts payable & accrued expense increased from Dec. 2020 (HK$123.3 Mil) to Dec. 2021 (HK$173.6 Mil) but then declined from Dec. 2021 (HK$173.6 Mil) to Dec. 2022 (HK$74.3 Mil).

Changmao Biochemical Engineering Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Accounts Payable & Accrued Expense Chart

Changmao Biochemical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

52.46

123.31

173.64

74.30

89.74

Changmao Biochemical Engineering Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															173.64	120.57	74.30	114.61	89.74

Changmao Biochemical Engineering Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034

Website

http://www.cmbec.com.hk

Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines